[Federal Register Volume 64, Number 222 (Thursday, November 18, 1999)]
[Notices]
[Page 63051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-30066]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting of Recombinant DNA Advisory Committee
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: December 8-10, 1999.
Time: December 8, 1999, 9 a.m. to 5 p.m.
Agenda: The Committee will discuss Proposed Actions under the
NIH Guidelines for Research Involving Recombinant DNA Molecules (59
FR 34496) and other matters to be considered by the Committee. The
Proposed Actions to be discussed will follow this notice of meeting.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 6, Bethesda, MD 20892.
Time: December 9, 1999, 8:30 a.m. to 5:00 p.m.
Agenda: See paragraph above for Agenda.
Place: National Institutes of Health, Building 31, Conference
Room 10, Bethesda, MD 20892.
Time: December 10, 1999, 8:30 a.m. to 5:00 p.m.
Agenda: See paragraph above for Agenda.
Place: National Institutes of Health, Building 31, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Debra W. Knorr, Deputy Director, Office of
Biotechnology Activities, NIH, MSC 7010, 6000 Executive Boulevard,
Suite 302, Bethesda, MD 20892-7010.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
Dated: November 1, 1999.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-30066 Filed 11-17-99; 8:45 am]
BILLING CODE 4140-01-M
